Is ImmunityBio, Inc. (IBRX) A Good Stock To Buy Now?
Is IBRX a good stock to buy? We came across a bullish thesis on ImmunityBio, Inc. on Investment Ideas by Antonio’s Substack by Antonio Linares.
Immunitybio Inc. (IBRX)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | D E Shaw D. E. Shaw | 12,571,597 | $96,424,149 | 0.06% | |
| 2. | Two Sigma Advisors John Overdeck And David Siegel | 4,385,500 | $33,636,785 | +284% | 0.03% |
| 3. | 3,824,900 | $29,336,983 | 0.06% | ||
| 4. | Woodline Partners Michael Rockefeller And Karl Kroeker | 3,447,346 | $26,441,144 | +1% | 0.1% |
| 5. | 3,000,800 | $23,016,136 | 5.29% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.75 | 485 | $1,333.75 | 71,915 | 2023-06-05 | Filing | |
| $2.77 | 48,000 | $132,960.00 | 71,430 | 2023-06-05 | Filing | |
| $2.72 | 23,430 | $63,729.60 | 23,430 | 2023-06-05 | Filing | |
| $2.90 | 10,000 | $29,000.00 | 25,000 | 2023-06-02 | Filing | |
| $2.80 | 10,000 | $28,000.00 | 15,000 | 2023-06-02 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $12.01 | 75,000 | $900,787.50 | 2,850,821 | 2026-02-24 | Filing | |
| $10.00 | 25,000 | $250,000.00 | 0 | 2026-02-23 | Filing | |
| $10.25 | 165,000 | $1,691,101.50 | 2,925,821 | 2026-02-23 | Filing | |
| $9.25 | 10,000 | $92,500.00 | 3,081,604 | 2026-02-20 | Filing | |
| $7.88 | 75,000 | $590,932.50 | 3,091,604 | 2026-01-20 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 26,346,443 | $202,077,217 | 0% | |
| 2. | 17,708,103 | $135,821,150 | 0% | |
| 3. | 16,322,844 | $125,196,213 | 0% | |
| 4. | 15,127,714 | $116,029,566 | 0% | |
| 5. | 8,031,921 | $61,616,480 | 0% |
News See All
10 Best Stocks to Buy in a Rising Market According to Wall Street Analysts
The equity market remains bullish, driven by a record-setting trend fueled by renewed enthusiasm for artificial intelligence.
ImmunityBio, Inc. (IBRX) Expands ANKTIVA Access With First Commercial Use in Saudi Arabia
TheFly reported on April 21 that ImmunityBio, Inc.
Top 10 AI-Powered Biotech Stocks to Buy Right Now
Franklin Equity reported on February 16 that, following a protracted period of uncertainty in the previous year, the biotechnology sector has entered 2026 on a firmer and more stable foundation.
Jim Cramer’s 16 Stock Calls, Including NVIDIA, Coterra, and Honeywell
In this article, we will look at Jim Cramer's recent stock calls on Mad Money.
11 Stocks With 3x-5x Returns This Year
The US stock market has endured a turbulent start to the year, with global crude oil prices spiking up and inflation surging to its highest level in two years, driven largely by the US-Israeli war on ...
10 Best Mid Cap Stocks to Invest In According to Billionaires
Venu Krishna, Managing Director and Head of U.S. Equity Strategy at Barclays, talked about the recent market increase and the implications for investors on April 2.
10 Best Performing Stocks of Q1 2026 to Watch for Q2
On April 3, Reuters reported that in the coming week, upcoming inflation data and initial company earnings could begin to show how the Middle East war is affecting the US economy and corporate America...
10 Stocks Dominating Today's Market Surge: ImmunityBio, Alkermes, and More
On the previous day, SoundHound AI (NASDAQ:SOUN) fell to a 52-week low of $5.83.
ImmunityBio Inc. (IBRX) Receives FDA Warning Letter Over Cancer Therapy Claims in Advertisement
ImmunityBio Inc. (NASDAQ:IBRX) is one of the best high growth healthcare stocks to buy now.